- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Histologically-confirmed Malignancies in United Kingdom
Total 870 results
-
MedImmune LLCCompletedCancer | B-cell MalignanciesUnited States, Italy, Belgium, Canada, Spain
-
Inovio PharmaceuticalsUniversity of PennsylvaniaCompletedAerodigestive Precancerous Lesions and MalignanciesUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedHER2 Positive MalignanciesUnited States
-
Gilead SciencesTerminatedHematological MalignanciesUnited States, United Kingdom
-
Zhuhai Yufan Biotechnologies Co., LtdRecruitingAdvanced Solid Tumor | Advanced Solid MalignanciesUnited States
-
AstraZenecaTerminatedSolid MalignanciesUnited States
-
Novartis PharmaceuticalsRecruitingALK Positive MalignanciesGermany, France, Australia, Belgium, Italy, Korea, Republic of, Poland, China, United States, Taiwan, Brazil, Bulgaria, Hong Kong, Japan, Lebanon, Malaysia, Spain, Russian Federation, Colombia, Singapore, Czechia
-
Baptist Health South FloridaWithdrawnNon-Hodgkin Lymphoma | Hematologic Malignancy | B-Cell Lymphoid MalignanciesUnited States
-
Abramson Cancer Center at Penn MedicineRecruitingWomen With Suspected or Confirmed Recurrent Breast CancerUnited States
-
Janssen Pharmaceutica N.V., BelgiumCompletedCritical Confirmed Coronavirus Disease (COVID)-19United States
-
AstraZenecaTerminatedCancer | Advanced Solid Tumors | Advanced Solid MalignanciesUnited States
-
AmgenTerminatedAdvanced Non-Central Nervous System (CNS) MalignanciesUnited States
-
AstraZenecaCompletedAdvanced Solid Malignancies | Breast Cancer - ER+, HER2 - | Breast Cancer - ER+, HER2-, PIK3CA Gene MutationUnited States, United Kingdom
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced or Metastatic Solid MalignanciesUnited States
-
BioMed Valley Discoveries, IncTerminatedSolid Tumor MalignanciesUnited States
-
NKGen Biotech, Inc.Active, not recruitingSolid Tumor | Metastatic Cancer | Advanced Solid Tumor | Advanced Cancer | Solid Tumor, Adult | Refractory Cancer | Recurrent Cancer | Pathologically Confirmed Cancer Refractory to Conventional TherapyUnited States
-
M.D. Anderson Cancer CenterNot yet recruitingBrain Malignancies | PseudoprogressionUnited States
-
AmgenCompletedHepatic Impairment | Solid Tumors | Hematologic MalignanciesUnited Kingdom, Netherlands, United States, France
-
Sidney Kimmel Comprehensive Cancer Center at Johns...United States Department of DefenseCompletedLocally Confined Adenocarcinoma of the ProstateUnited States
-
Case Comprehensive Cancer CenterTerminatedGynecologic MalignanciesUnited States
-
Novita Pharmaceuticals, Inc.RecruitingAdvanced or Metastatic Solid Tumor MalignanciesUnited States
-
Northwell HealthCompletedPostpartum Depression | Unspecified Child Maltreatment, Suspected | Unspecified Child Maltreatment, ConfirmedUnited States
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited States, Germany, Italy, United Kingdom, Canada, France, Korea, Republic of, Netherlands
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)CompletedCancer MalignanciesUnited States
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHuman Papillomavirus (HPV)-Related Malignancies | Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related MalignanciesUnited States
-
Catherine BollardJohns Hopkins University; Children's National Research InstituteRecruitingRelapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDSUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedPatients With Lung, Breast, Head and Neck, or Pelvic MalignanciesUnited States
-
Lahey ClinicCompletedGastrointestinal and Gynecologic MalignanciesUnited States
-
Wake Forest University Health SciencesCompleted
-
Eisai Inc.CompletedPatients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LECUnited States
-
University College, LondonActive, not recruitingBurkitt Lymphoma | Acute Lymphoblastic LeukemiaUnited Kingdom
-
AstraZenecaActive, not recruitingPediatric Cancer | Hematological Malignancies | Solid Tumor PediatricSpain, Italy, United States, United Kingdom, France, Netherlands, Germany
-
Genentech, Inc.CompletedHematologic Malignancies | TumorsSpain, France, United States, United Kingdom
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingConfirmed Diagnosis of ß-thalassemia MajorUnited States
-
Incyte Biosciences International SàrlCompletedMetastatic Cancer | Advanced MalignanciesUnited States, United Kingdom, Spain, Switzerland
-
Calithera Biosciences, IncCompletedAdvanced Solid Tumor and Lymphoma MalignanciesUnited States, Spain, Italy, United Kingdom
-
BioMed Valley Discoveries, IncCompletedSolid Tumor MalignanciesUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingSolid Tumor MalignanciesUnited States
-
Incyte CorporationCompletedAdvanced MalignanciesUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedMetastatic Solid Tumors, Refractory/Relapsed Hematologic MalignanciesUnited States
-
National Cancer Institute (NCI)RecruitingLymphoma | Non-Hodgkin Lymphoma | NHL | Hematologic Malignancies | Lymphoid MalignanciesUnited States
-
Northwell HealthCompletedMediastinal Lymphadenopathy | Lung MalignanciesUnited States
-
Notitia Biotechnologies CompanyUniversity of South Florida; Rutgers UniversityCompletedSuspected or Confirmed COVID-19United States
-
GlaxoSmithKlineCompletedNeoplasmsSpain, United States, Korea, Republic of, United Kingdom, Australia
-
M.D. Anderson Cancer CenterTerminatedLeukemia | Metastatic Malignant Neoplasm to the Leptomeninges | Lymphoid MalignanciesUnited States
-
Acrotech Biopharma Inc.Axis Clinicals LimitedTerminatedRelapsed/Refractory Solid Tumors/Hematological MalignanciesUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingHematologic MalignanciesUnited States
-
Janssen Research & Development, LLCCompletedHematologic MalignanciesUnited States
-
University of Illinois at ChicagoTerminatedHematologic MalignanciesUnited States